Ads by Google

Drug Clinical Trials

Low-Dose Steroid Combined With Lenalidomide Prolongs Survival For Multiple Myeloma Treatment

Preliminary results from a large, randomized clinical trial for patients with newly diagnosed multiple myeloma has shown that the use of a low dose of the steroid dexamethasone, in combination with lenalidomide is associated with improved survival when compared to a treatment regimen with lenalidomide and a higher, standard dose of dexamethasone.

Health and Wellness: 

Novagali Pharma Announces Positive Vekacia Clinical Results From Pivotal Phase III Trial

Novagali Pharma, an emerging ophthalmic pharmaceutical company specialized in ophthalmology, announces today positive results from the Phase III clinical study of Vekacia in children suffering from Vernal Keratoconjunctivitis.

Health and Wellness: 

Viventia Biotech Initiates Patient Treatment For Vicinium Phase II Bladder Cancer Trial

Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody products focused on cancer, announced today that it has initiated patient treatment in its open-label Phase II clinical trial for Vicinium, administered using intravesical instillation for the treatment of locally persistent non-invasive bladder cancer.

Health and Wellness: 

Pages